BELGRADE, Mont., June 19, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the signing of an agreement with Yankee Alliance, a group purchasing organization (GPO) with more than 11,500 members. The agreement covers Bacterin’s complete line of biologic implants, including 3Demin cortical fiber allografts. The contract is a three-year agreement extending through June 2018.
“Yankee Alliance works hard to contract with suppliers who deliver quality products that provide all-around value,” said Bob Di Silvio, President of Bacterin. “This new contract will allow Yankee Alliance Members to access Bacterin’s entire portfolio of best in class biomaterials. We look forward to growing our relationship with Yankee Alliance.”
This is the first GPO to include Bacterin’s 3Demin family of allografts. The 3Demin Boats, Strips, and Fibers were developed to compete in the domestic bone replacement market, a $1.7 billion annual business segment (Source: BioMedGPS, LLC), and serve as a complement to our proprietary demineralized bone matrix (DBM) portfolio. Since launching 3Demin in late 2014, Bacterin has experienced positive adoption of this new allograft category and anticipates it will continue to contribute to Bacterin’s growth. In addition to this agreement, Yankee Alliance has access to Bacterin’s full product portfolio of allografts through their affiliation with Premier, Inc., in which Bacterin serves as a contracted biologics supplier.
